GILD NASDAQ

Gilead Sciences

Follow Open structure map Ask about this Research this company

Description

GILD · NASDAQ

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.

Wikipedia · CC BY-SA 4.0

Headquarters: US
Reporting currency: USD
Website: Website

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Filings

10-QPeriod end 2026-06-30Filed 2026-08-06 8-KPeriod end 2026-08-04Filed 2026-08-04 8-KPeriod end 2026-05-14Filed 2026-05-20 10-QPeriod end 2026-03-31Filed 2026-05-07 8-KPeriod end 2026-05-07Filed 2026-05-07 8-KPeriod end 2026-04-30Filed 2026-05-04 8-KPeriod end 2026-04-28Filed 2026-04-28 10-KPeriod end 2025-12-31Filed 2026-02-24 8-KPeriod end 2026-02-22Filed 2026-02-23 8-KPeriod end 2026-02-10Filed 2026-02-10 8-KPeriod end 2025-11-15Filed 2025-11-19 10-QPeriod end 2025-09-30Filed 2025-11-07 8-KPeriod end 2025-10-30Filed 2025-10-30 8-KPeriod end 2025-10-06Filed 2025-10-06 8-KPeriod end 2025-08-10Filed 2025-08-14 10-QPeriod end 2025-06-30Filed 2025-08-07 8-KPeriod end 2025-08-07Filed 2025-08-07 8-KPeriod end 2025-07-30Filed 2025-08-04 8-KPeriod end 2025-05-07Filed 2025-05-08 10-QPeriod end 2025-03-31Filed 2025-05-07

Not available: Company signals · Relations · Claims · Financials · Guidance